Skip to main content
Top
Published in: BMC Pediatrics 1/2014

Open Access 01-12-2014 | Research article

Association between altered placental human chorionic gonadotrophin (hCG) production and the occurrence of cryptorchidism: a retrospective study

Authors: Carole Chedane, Hugues Puissant, Dominique Weil, Stéphanie Rouleau, Régis Coutant

Published in: BMC Pediatrics | Issue 1/2014

Login to get access

Abstract

Background

An increase in cryptorchidism has been reported in many countries. One mechanism could be low fetal testosterone production possibly secondary to altered placental human chorionic gonadotrophin (hCG) release. Our Objective was to compare hCG values from maternal blood between boys with cryptorchidism and normal boys.

Methods

Total hCG and α-fetoprotein (AFP) values [12–16 weeks of gestation; from the double test for Down syndrome screening) were compared between cases of cryptorchidism and normal control boys who were matched for maternal age, maternal smoking, gestational age at time of hCG measurement (±1 day), birth weight and birth term. Measurements were performed in a single laboratory; values were expressed as absolute values (KU/L) and multiples of the median (MoM). Boys whose mothers had had a complicated pregnancy were excluded. Groups were compared using the Student’s t test. Log transformation was used to normalize hCG, MoM hCG, AFP and MoM AFP distribution, and values were expressed as geometric means (-1, + 1 tolerance factor).

Results

Total hCG and MoM hCG levels were significantly lower in the 51 boys with cryptorchidism compared to 306 controls (21.4 (12.3; 37) KU/L vs 27.7 (15.9; 47.9) KU/L and 0.8 (0.5; 1.2) MoM vs 1.0 (0.6; 1.6) MoM, respectively, p < 0.01). By contrast, AFP and MoM AFP levels were similar between groups.

Conclusion

This study showed a link between low maternal serum hCG levels and cryptorchidism in boys from uncomplicated pregnancy, while normal AFP levels indicated a normal fetoplacental unit. Whether these abnormalities were due to endogenous or exogenous factors remains to be determined.
Literature
1.
2.
go back to reference Akre O, Lipworth L, Cnattingius S, Sparen P, Ekborn A: Risk factor patterns for cryptorchidism and hypospadias. Epidemiology. 1999, 10: 364-369. 10.1097/00001648-199907000-00005.CrossRefPubMed Akre O, Lipworth L, Cnattingius S, Sparen P, Ekborn A: Risk factor patterns for cryptorchidism and hypospadias. Epidemiology. 1999, 10: 364-369. 10.1097/00001648-199907000-00005.CrossRefPubMed
3.
go back to reference Willingham E, Baskin LS: Candidate genes and their response to environmental agents in the etiology of hypospadias. Nat Clin Pract Urol. 2007, 4: 270-279.CrossRefPubMed Willingham E, Baskin LS: Candidate genes and their response to environmental agents in the etiology of hypospadias. Nat Clin Pract Urol. 2007, 4: 270-279.CrossRefPubMed
4.
go back to reference Scott HM, Mason JI, Sharpe RM: Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev. 2009, 30: 883-925. 10.1210/er.2009-0016.CrossRefPubMed Scott HM, Mason JI, Sharpe RM: Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr Rev. 2009, 30: 883-925. 10.1210/er.2009-0016.CrossRefPubMed
5.
go back to reference Achermann JC, Hughes IA: Disorders of sex development. Williams textbook of Endocrinology. Edited by: Konenberg HM, Melmed S, Polonsky KS, Reed Larsen P. 2012, Saunders Elsevier, 783-848. Achermann JC, Hughes IA: Disorders of sex development. Williams textbook of Endocrinology. Edited by: Konenberg HM, Melmed S, Polonsky KS, Reed Larsen P. 2012, Saunders Elsevier, 783-848.
6.
go back to reference Vigueras RM, Reyes G, Moreno-Mendoza N, Merchant-Larios H: Gubernacular fibroblasts express the androgen receptor during testis descent in cryptorchid rats treated with human chorionic gonadotrophin. Urol Res. 2004, 32: 386-390. 10.1007/s00240-004-0408-8.CrossRefPubMed Vigueras RM, Reyes G, Moreno-Mendoza N, Merchant-Larios H: Gubernacular fibroblasts express the androgen receptor during testis descent in cryptorchid rats treated with human chorionic gonadotrophin. Urol Res. 2004, 32: 386-390. 10.1007/s00240-004-0408-8.CrossRefPubMed
7.
go back to reference Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM: Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008, 118: 1479-1490. 10.1172/JCI34241.CrossRefPubMedPubMedCentral Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM: Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008, 118: 1479-1490. 10.1172/JCI34241.CrossRefPubMedPubMedCentral
8.
go back to reference Newbold RR: Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004, 199: 142-150. 10.1016/j.taap.2003.11.033.CrossRefPubMed Newbold RR: Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol. 2004, 199: 142-150. 10.1016/j.taap.2003.11.033.CrossRefPubMed
9.
go back to reference Siler-Khodr TM, Khodr GS, Valenzuela G, Rhode J: Gonadotropin-releasing hormone effects on placental hormones during gestation: II. Progesterone, estrone, estradiol and estriol. Biol Reprod. 1986, 34: 255-264. 10.1095/biolreprod34.2.255.CrossRefPubMed Siler-Khodr TM, Khodr GS, Valenzuela G, Rhode J: Gonadotropin-releasing hormone effects on placental hormones during gestation: II. Progesterone, estrone, estradiol and estriol. Biol Reprod. 1986, 34: 255-264. 10.1095/biolreprod34.2.255.CrossRefPubMed
10.
go back to reference Rama S, Rao AJ: Embryo implantation and GnRH antagonists. The search for the human placental GnRH receptor. Hum Reprod. 2001, 16: 201-205. 10.1093/humrep/16.2.201.CrossRefPubMed Rama S, Rao AJ: Embryo implantation and GnRH antagonists. The search for the human placental GnRH receptor. Hum Reprod. 2001, 16: 201-205. 10.1093/humrep/16.2.201.CrossRefPubMed
11.
go back to reference Kiely EA, Chapman RS, Bajoria SK, Hollyer JS, Hurley R: Maternal serum human chorionic gonadotrophin during early pregnancy resulting in boys with hypospadias or cryptorchidism. Br J Urol. 1995, 76: 389-392. 10.1111/j.1464-410X.1995.tb07720.x.CrossRefPubMed Kiely EA, Chapman RS, Bajoria SK, Hollyer JS, Hurley R: Maternal serum human chorionic gonadotrophin during early pregnancy resulting in boys with hypospadias or cryptorchidism. Br J Urol. 1995, 76: 389-392. 10.1111/j.1464-410X.1995.tb07720.x.CrossRefPubMed
12.
go back to reference Burton M, Davies T, Raggatt P: Undescended testis and hormone levels in early pregnancy. J Epidemiol Comm Health. 1987, 41: 127-129. 10.1136/jech.41.2.127.CrossRef Burton M, Davies T, Raggatt P: Undescended testis and hormone levels in early pregnancy. J Epidemiol Comm Health. 1987, 41: 127-129. 10.1136/jech.41.2.127.CrossRef
13.
go back to reference Bernstein L, Pike M, Depue R, Ross RK, Moore JW, Henderson BE: Maternal hormone levels in early gestation of cryptorchid males: a case–control study. Br J Cancer. 1988, 58: 379-381. 10.1038/bjc.1988.223.CrossRefPubMedPubMedCentral Bernstein L, Pike M, Depue R, Ross RK, Moore JW, Henderson BE: Maternal hormone levels in early gestation of cryptorchid males: a case–control study. Br J Cancer. 1988, 58: 379-381. 10.1038/bjc.1988.223.CrossRefPubMedPubMedCentral
14.
go back to reference Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA: Maternal serum screening for Down’s syndrome in early pregnancy. BMJ. 1988, 297: 883-887. 10.1136/bmj.297.6653.883.CrossRefPubMedPubMedCentral Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA: Maternal serum screening for Down’s syndrome in early pregnancy. BMJ. 1988, 297: 883-887. 10.1136/bmj.297.6653.883.CrossRefPubMedPubMedCentral
15.
go back to reference Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D: Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol. 1992, 99: 144-149. 10.1111/j.1471-0528.1992.tb14474.x.CrossRefPubMed Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D: Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol. 1992, 99: 144-149. 10.1111/j.1471-0528.1992.tb14474.x.CrossRefPubMed
16.
go back to reference Boyd HA, Myrup C, Wohlfahrt J, Westergaard T, Norgaard-Pedersen B, Melbye M: Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring. Am J Epidemiol. 2006, 164: 478-486. 10.1093/aje/kwj219.CrossRefPubMed Boyd HA, Myrup C, Wohlfahrt J, Westergaard T, Norgaard-Pedersen B, Melbye M: Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring. Am J Epidemiol. 2006, 164: 478-486. 10.1093/aje/kwj219.CrossRefPubMed
Metadata
Title
Association between altered placental human chorionic gonadotrophin (hCG) production and the occurrence of cryptorchidism: a retrospective study
Authors
Carole Chedane
Hugues Puissant
Dominique Weil
Stéphanie Rouleau
Régis Coutant
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2014
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/1471-2431-14-191

Other articles of this Issue 1/2014

BMC Pediatrics 1/2014 Go to the issue